Results 31 to 40 of about 304,930 (167)
BackgroundAcute Respiratory Distress Syndrome (ARDS) is a severe lung condition posing significant health risks. Observational studies have indicated a potential linkage between ARDS and various interleukins, such as Interleukin-8, −2, −6, and −1β ...
Jia-wei Ma +3 more
doaj +1 more source
Search for molecular genetic markers of risk and prognosis of breast cancer is an important prospective of modern research. Many molecular mechanisms are involved in pathogenesis of breast cancer and define a wide range of possible candidate genes.
A. N. Silkov +3 more
doaj +1 more source
Aryl hydrocarbon receptor (AhR) — transcription factor activated by a large number of environmental agents, and may play a role in the pathogenesis of inflammatory bowel diseases in humans and mouse models.
O.S. Zherebiatiev, O.M. Kamyshnyi
doaj +1 more source
Interleukin‐1 receptor accessory protein interacts with the type II interleukin‐1 receptor
Stably transfected HEK‐293 cells express on their surface the murine type II IL‐1 receptor (mIL‐1RII) as demonstrated by FACS analysis using the mAb 4E2, however binding of [125I]‐hrIL‐1β to these cells is nearly absent. Saturable high affinity binding of [125I]‐hrIL‐1β is observed when the murine IL‐1 receptor accessory protein (mIL‐1RAcP) is ...
Malinowsky, David +3 more
openaire +2 more sources
MicroRNAs and Toll-like Receptor/Interleukin-1 Receptor Signaling
The discovery of miRNAs has revolutionized the way we examine the genome, RNA products, and the regulation of transcription and translation. Their ability to modulate protein expression through mRNA degradation and translation repression resulted in avid
Virtue Anthony +2 more
doaj +1 more source
Interleukin-1 receptors and receptor antagonist in haemodialysis [PDF]
Biological activity of interleukin-1 (IL-1) depends on the number and type of IL-1 receptors on target cells and on the amounts of its naturally occurring inhibitor, the IL-1 receptor antagonist (IL-1ra).Expression of IL-1 receptor was studied on the peripheral blood mononuclear cells of 20 end-stage renal-disease patients maintained by chronic ...
DONATI D. +6 more
openaire +3 more sources
The interleukin-1 receptor antagonist (IL-1ra) inhibits the binding of interleukin-1 (IL-1) to T-cell lines possessing the type I IL-1 receptor; evidence has been published (Carter, D. B., Deibel, M. R. J., Dunn, C. J., Tomich, C. S., Laborde, A. L., Slightom, J. L., Berger, A. E., Bienkowski, M. J., Sun, F. F., McEwan, R. N., Harris, P. K. W., Yem, A.
E V, Granowitz +3 more
openaire +2 more sources
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Depression is a multicausal disorder and has been associated with the risk to develop cancer, dementia, diabetes, epilepsy and stroke. As a metabolic disorder depression has been associated with obesity, diabetes, insulin sensitivity, neuropeptide Y ...
Undine E. Lang, Stefan Borgwardt
doaj +1 more source
Lower respiratory tract infections (LRTI) are often caused by Streptococcus pneumoniae (Spn) and can be recurrent in 8% of children older than 2 years of age.
Johan N. Siebert +10 more
doaj +1 more source
Background Interleukin (IL)-38 is an IL-1 family cytokine that was proposed to exert anti-inflammatory effects. However, its mechanisms of action are not well understood and the identity of the IL-38 receptor(s) remains debated.
Alejandro Diaz-Barreiro +8 more
doaj +1 more source

